Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Non Cancer Pain × Oxycodone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 12 Neoplasms 11 Cancer Pain 11 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma 2 Bronchiolitis Obliterans Syndrome 2 Acute Pain 2 Waldenstrom Macroglobulinemia 1 Trigger Finger Disorder 1 Thrombocythemia, Essential 1 Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pain, Postoperative 1 Opioid-Induced Constipation 1 Nutrition Disorders 1 Non Cancer Pain 1 Neuralgia 1 Neoplasms, Plasma Cell 1 Nasopharyngeal Carcinoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01918098 2017-11-14

Targin for Non-cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed

Non Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡